AP vs ULBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AP's deterministic health scores signal significant financial distress: the Piotroski F-Score of 2/9 indicates weak operational and financial health, while the absence of an Altman Z-Score raises red flags for potential bankruptcy risk. Despite a strong 12.3% YoY revenue growth and recent earnings surprises, the company reports negative net profit margins (-1.24%) and ROE (-4.08%), with a dangerously high debt/equity ratio of 1.88. The stock trades at a premium valuation (Forward P/E: 28.83, Price/Book: 2.23) despite poor profitability and no dividend, suggesting overvaluation. Technical trends are bearish, and insider activity is neutral, offering no conviction.
ULBI presents a contradictory profile: a stable Piotroski F-Score of 6/9 and strong liquidity are offset by deteriorating profitability and severe earnings misses. While the stock trades attractively on a Price-to-Book (0.99) and Price-to-Sales (0.68) basis, the negative profit margins and a high PEG ratio (3.81) suggest that the recent price surge is disconnected from fundamental earnings growth. The company's stability is anchored by a low Debt/Equity ratio (0.41), but high customer concentration and consistent EPS underperformance create significant risk.
Compare Another Pair
AP vs ULBI: Head-to-Head Comparison
This page compares Ampco-Pittsburgh Corporation (AP) and Ultralife Corporation (ULBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.